CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,014 | +4.4% | 600 | +20.0% | 0.00% | – |
| Q2 2023 | $6,720 | +102.7% | 500 | +150.0% | 0.00% | – |
| Q1 2023 | $3,316 | +122.8% | 200 | +150.0% | 0.00% | – |
| Q4 2022 | $1,488 | +48.8% | 80 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -100.0% | 80 | -98.5% | 0.00% | – |
| Q1 2021 | $23,972,000 | +266255.6% | 5,200 | +108.0% | 0.00% | – |
| Q4 2019 | $9,000 | -60.9% | 2,500 | -44.4% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | +155.6% | 4,500 | +80.0% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |